These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12473799)

  • 41. The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia.
    Walleser S; Salkeld G; Donovan B
    Sex Health; 2006 Dec; 3(4):225-34. PubMed ID: 17112432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The risk of pelvic inflammatory disease associated with urogenital infection with Chlamydia trachomatis; literature review].
    Boeke AJ; van Bergen JE; Morré SA; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):878-84. PubMed ID: 15868993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: which strategy is more cost-effective?
    Chen S; Li J; van den Hoek A
    Sex Transm Dis; 2007 Apr; 34(4):230-6. PubMed ID: 17414068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project.
    Roberts TE; Robinson S; Barton PM; Bryan S; McCarthy A; Macleod J; Egger M; Low N
    BMJ; 2007 Aug; 335(7614):291. PubMed ID: 17656504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.
    de Wit GA; Over EA; Schmid BV; van Bergen JE; van den Broek IV; van der Sande MA; Welte R; Op de Coul EL; Kretzschmar ME
    Sex Transm Infect; 2015 Sep; 91(6):423-9. PubMed ID: 25759475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modelling the impact of opportunistic screening on the sequelae and public healthcare costs of infection with Chlamydia trachomatis in Australian women.
    Ward B; Rodger AJ; Jackson TJ
    Public Health; 2006 Jan; 120(1):42-9. PubMed ID: 16271271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program.
    Blake DR; Quinn TC; Gaydos CA
    Sex Transm Dis; 2008 Jan; 35(1):91-101. PubMed ID: 18217229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlamydia screening for pregnant women aged 16-25 years attending an antenatal service: a cost-effectiveness study.
    Ong JJ; Chen M; Hocking J; Fairley CK; Carter R; Bulfone L; Hsueh A
    BJOG; 2016 Jun; 123(7):1194-202. PubMed ID: 26307516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The utility and cost of Chlamydia trachomatis and Neisseria gonorrhoeae screening of a male infertility population.
    Domes T; Lo KC; Grober ED; Mullen JB; Mazzulli T; Jarvi K
    Fertil Steril; 2012 Feb; 97(2):299-305. PubMed ID: 22192351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cost effectiveness of opportunistic chlamydia screening in England.
    Adams EJ; Turner KM; Edmunds WJ
    Sex Transm Infect; 2007 Jul; 83(4):267-74; discussion 274-5. PubMed ID: 17475686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health and cost-benefits of chlamydia screening in young women.
    Mangione-Smith R; O'Leary J; McGlynn EA
    Sex Transm Dis; 1999 Jul; 26(6):309-16. PubMed ID: 10417017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing genital chlamydia trachomatis infection in Scotland: targeted opportunistic testing or a screening programme?
    Clutterbuck DJ
    Health Bull (Edinb); 2001 Nov; 59(6):396-404. PubMed ID: 12661390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
    Morré SA; van den Brule AJ; Rozendaal L; Boeke AJ; Voorhorst FJ; de Blok S; Meijer CJ
    Int J STD AIDS; 2002 Dec; 13 Suppl 2():12-8. PubMed ID: 12537719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for Chlamydia trachomatis infection in 6810 young women attending family planning clinics.
    Ramstedt K; Forssman L; Giesecke J; Granath F
    Int J STD AIDS; 1992; 3(2):117-22. PubMed ID: 1571382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementing chlamydia screening: what do women think? A systematic review of the literature.
    Pavlin NL; Gunn JM; Parker R; Fairley CK; Hocking J
    BMC Public Health; 2006 Sep; 6():221. PubMed ID: 16948838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infection in women.
    Gupta M; Hernon M; Gokhale R; Ghosh AK
    Sex Transm Infect; 2002 Feb; 78(1):76. PubMed ID: 11872877
    [No Abstract]   [Full Text] [Related]  

  • 58. Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis.
    Nettleman MD; Jones RB
    JAMA; 1988 Jul; 260(2):207-13. PubMed ID: 3133496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males.
    Shafer MA; Schachter J; Moncada J; Keogh J; Pantell R; Gourlay L; Eyre S; Boyer CB
    JAMA; 1993 Nov; 270(17):2065-70. PubMed ID: 8411573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.
    Herzog SA; Heijne JC; Scott P; Althaus CL; Low N
    Epidemiology; 2013 Nov; 24(6):854-62. PubMed ID: 24076992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.